JRJon Reed

Jon Reed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jon Reed has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Correction to: Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury

    by Tanja Emmerich, Laila Abdullah, Joseph Ojo, Benoit Mouzon, Thinh Nguyen, Gogce Crynen, James E. Evans, Jon Reed, Michael Mullan, Fiona Crawford

    The original version of this article unfortunately contained a mistake. Gary S. Laco should not be listed as an author in the author group.

  • Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury

    by Tanja Emmerich, Laila Abdullah, Joseph Ojo, Benoit Mouzon, Thinh Nguyen, Gary S. Laco, Gogce Crynen, James E. Evans, Jon Reed, Michael Mullan, et al.

    Neurophysiological and neurological dysfunction is usually experienced for a short period of time in patients with mild traumatic brain injury (mTBI). However, around 15 % of patients exhibit symptoms months after TBI. Phospholipid (PL) changes have been observed in plasma from mTBI patients at chronic stages, suggesting a role in TBI pathology. We examined long-term plasma phospholipid profiles in a mouse model of mTBI to determine their translational value in reproducing PL changes observed in mTBI patients. Plasma samples were collected at an acute timepoint (24 h post-injury) and at several chronic stages (3, 6, 12 and 24 months post-injury) from injured mice and sham controls. Phospholipids were identified and quantified using liquid chromatography/mass spectrometry analysis. In accordance with human data, we observed significantly lower levels of several major PL classes in mTBI mice compared to controls at chronic timepoints. Saturated, monounsaturated and polyunsaturated fatty acids (PUFAs) were differently regulated over time. As PUFA levels were decreased at 3 months, we measured levels of malondialdehyde to assess lipid peroxidation, which we found to be elevated at this timepoint. Ether-containing PE species were elevated at 24 h post-injury and decreased relative to controls at chronic stages. Arachidonic acid and docosahexaenoic acid-containing species were significantly decreased within all PL classes at the chronic stages. Our findings are similar to changes in PL levels observed in human mTBI subjects. Chronic TBI biomarkers have received little attention, even though disabilities at this stage can be of major importance. Our study provides information on biochemical abnormalities that persist long after the initial injury; these abnormalities may provide useful insight into the continuing pathogenesis and serve as diagnostic biomarkers.


  • Plasma Lipidomic Profiling in a Military Population of Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder with Apolipoprotein E ɛ4–Dependent Effect

    by Tanja Emmerich, Laila Abdullah, Gogce Crynen, Michael Dretsch, James Evans, Ghania Ait-Ghenzala, Jon Reed, Hannah Montague, Helena Chaytow, Venkatarajan Mathura, et al.

    In the military population, there is high comorbidity between mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) due to the inherent risk of psychological trauma associated with combat. These disorders present with long-term neurological dysfunction and remain difficult to diagnose owing to their comorbidity and overlapping clinical presentation. Therefore, we performed cross-sectional analysis of blood samples from demographically matched soldiers (total n = 120) with mTBI, PTSD and mTBI + PTSD and those who were considered cognitively and psychologically normal. Soldiers were genotyped for apolipoprotein E (APOE) ε4 and phospholipids (PL) were examined using liquid chromatography/mass spectrometry (LC/MS) analysis. We observed significantly lower levels of several major PL classes in TBI, PTSD and TBI+PTSD compared to controls. PTSD severity analysis revealed that significant PL decreases were primarily restricted to the moderate-to-severe PTSD group. An examination of degree of unsaturation showed that monounsaturated fatty acid (MUFA) containing phosphatidylcholine (PC) and phosphatidylinositol (PI) species were lower in the TBI and TBI+PTSD groups. However these PLs were unaltered among PTSD subjects compared to controls. Similarly, ether PC (ePC) levels were lower in PTSD and TBI+PTSD subjects relative to controls. Ratios of arachidonic acid (AA) to docosahexaenoic acid (DHA) containing species were significantly decreased within PC and PE classes. APOE ε4 (+) subjects exhibited higher PL levels than their APOE ε4 (-) counterparts within same diagnostic groups. These findings suggest that PL profiles, together with APOE genotyping, could potentially aid to differentiate diagnosis of mTBI and PTSD and warrant further validation. In conclusion, PL profiling may facilitate clinical diagnosis of mTBI and PTSD, currently hindered by comorbid pathology and overlapping symptomology of these two conditions.


  • Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer’s disease

    by Pancham Bakshi, Elaina Margenthaler, Jon Reed, Fiona Crawford, Michael Mullan


  • North American Brain Injury Societyʼs Ninth Annual Conference on Brain Injury

    by Fiona Crawford, Gogce Crynen, Jon Reed, Benoit Mouzon, Alex Bishop, Benjamin Katz, Scott Ferguson, John Phillips, Vani Ganapathi, Venkatarajan Mathura, et al.